To examine the role of the Irg1/itaconate pathway in asthma, we utilize repeated HDM challenge with low dose STING agonist cyclic-di-GMP (c-di-GMP) administration, which is a mucosal adjuvant and acts as an innate immune sensor. This evidence concerns the gene STING1 and asthma.